Navigation Links
Nexavar in Combination With Chemotherapy Demonstrates 74 Percent Improvement in Progression-Free Survival in Patients With Advanced Breast Cancer in Phase 2 Study
Date:9/23/2009

BERLIN, Sept. 23 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the full results from their first collaborative group-sponsored randomized, double-blind, placebo-controlled Phase 2 trial showing that Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic agent, capecitabine, significantly extended progression-free survival in patients with advanced breast cancer. The data were presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress in Berlin.

Jose Baselga, M.D., chairman and professor of medicine at Vall d'Hebron Institute of Oncology in Barcelona, scientific chairman of SOLTI and the principal investigator of this study, reported that patients receiving Nexavar plus capecitabine had a 74 percent improvement in the time they lived without their disease progressing compared to those who received the chemotherapy alone. The difference in median progression-free survival of Nexavar plus capecitabine versus capecitabine plus placebo was statistically significant, 6.4 months vs. 4.1 months (HR=.576, p=0.0006).

"Onyx and Bayer have built a strong foundation with Nexavar in treating unresectable liver cancer and advanced kidney cancer - both disease areas with a previously unmet treatment need," said Todd Yancey, M.D., vice president of clinical development at Onyx. "These new results signify another step in understanding the potential role of Nexavar in breast cancer."

The study evaluated Nexavar in combination with the oral chemotherapeutic, capecitabine, in patients with locally advanced or metastatic HER-2 negative breast cancer. Overall, treatment with Nexavar plus capecitab
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
2. Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer
3. Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
4. Phase 3 Trial Initiated to Evaluate Combination Therapy of Nexavar(R) and Tarceva(R) in Patients with Liver Cancer
5. Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
6. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
7. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
8. More Sleep & Less Sex - A Losing Combination
9. Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
10. Diabetes Drug Kills Cancer Stem Cells in Combination Treatment in Mice
11. Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... ... Sculpted Contours Luxury Medical Aesthetics announces the arrival of the newest applicator ... new applicator in the United States as an upgrade to the CoolSmooth applicator cleared ... applicator required a 2 hour treatment time. The new CoolSmooth Pro reduces the ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Coco Libre ... athletes, judges, media, and VIPs at the 2015 Vans US Open of Surfing, July ... water that can claim “no added sugar” on the market, is a natural choice ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article published ... if they could reach a consensus on the steps that need to be taken ... group reached 90 percent consensus on a series of steps that each surgeon must ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... As part ... believes community involvement and support of animal welfare organizations is essential to the longevity ... third consecutive year in the National Association of Professional Pet Sitters (NAPPS) annual Presents ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: Don’t ... the industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International ... event attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers and ...
Breaking Medicine News(10 mins):Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 2Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 3Health News:Dallas-based Park Cities Pet Sitter Selects Non-Profit Animal Welfare Organization “Angie’s Friends” as this Year’s Recipient of their Presents 4 Pets Supply Drive. 4Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3
... BOSTON -- The temptation to rely on media screens to ... screens surrounding families at home, in the car, and even ... media products and programming targeted to little ones. But a ... says there are better ways to help children learn at ...
... MONDAY, Oct. 17 (HealthDay News) -- A trusted hairdresser may be ... hair color and maybe even the name of your plastic ... telltale signs of deadly skin cancer. "Hairdressers and barbers can ... they are trained on how to look at the skin for ...
... It is well known that eating disorders are common ... another well-known unhealthy habit of this age group. A ... when college students combine these two unhealthy habits, their ... term coined by the media to describe the combination ...
... use of surgery to treat early-stage laryngeal cancer (cancer of ... chemotherapy in combination with radiation therapy is being used increasingly ... according to a report in the October issue of ... of the JAMA/Archives journals. Cancer of the larynx, or ...
... in the palliative stage of cancer favour aggressive chemotherapy ... an article in CMAJ (Canadian Medical Association Journal) (pre-embargo ... second most common cause of death for children aged ... unlikely the cancer will be cured, parents and health ...
... just released by the Alberta Diabetes Surveillance System (ADSS) shows ... providers and more effective use of medical records to aid ... and prevent long-term complications of the disease. This is ... additional sources of data. With this enhancement it has become ...
Cached Medicine News:Health News:Babies and toddlers should learn from play, not screens 2Health News:Babies and toddlers should learn from play, not screens 3Health News:Skin Cancer Check May Come With New Hairdo 2Health News:Skin Cancer Check May Come With New Hairdo 3Health News:'Drunkorexia:' A recipe for disaster 2Health News:More surgery in early-stage laryngeal cancer treatment; more chemoradiation for advanced-stage 2Health News:Pediatric cancer and palliative care: parental preferences compared with health-care professionals 2Health News:New provincial atlas; information on lab testing key to managing diabetes among Albertans 2
(Date:7/30/2015)... ROCHELLE PARK, N.J. , July 30, 2015 /PRNewswire/ ... is voluntarily recalling one lot of Hydrochlorothiazide tablets 25 ... has been initiated as a precautionary measure due to ... bottle of the product. The risk ... a Hydrochlorothiazide tablet is the increased probability of experiencing ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... , July 30, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Biosensors Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) Explore ...
Breaking Medicine Technology:Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5
... MANOR, N.Y., Aug. 17, 2011 Polymedco is ... "Organized Colorectal Cancer Screening in Integrated Health Care ... A Burley, Juan Reyes, Michael Oehrli, and Cindy ... organized screening program for Colorectal cancer (CRC) at ...
... 2011 Trinity Pharma Solutions (Trinity ... intelligence (BI) that brings the benefits of SaaS ... TrinityAgile , Trinity Pharma helps life sciences ... adaptability and deliver commercial results. (Logo: ...
Cached Medicine Technology:Polymedco Announces Publication in Epidemiologic Reviews 2Trinity Pharma Solutions Brings SaaS Benefits to Life Sciences Industry with Rapid Access to Actionable Sales Intelligence 2Trinity Pharma Solutions Brings SaaS Benefits to Life Sciences Industry with Rapid Access to Actionable Sales Intelligence 3
Inquiry 4Fr, 5Fr and 6Fr diagnostic electrophysiology catheters offer simple, precise distal control with it's patented Easy-Hand steering mechanism....
The Arrow 2 Fr. QuadPolar electrode catheter and triple lumen guide system is designed for faster and easier electrophysiology studies. The 2 Fr. QuadPolar catheter is highly torqueable, radiopaque, ...
... To aid clinicians in performing Ankle/Brachial ... a new, complete packet of information. It ... presentation that can be viewed on any ... the step-by-step procedure of performing an ABI ...
... Clamp, compatible with the full line of ... force on all three skull pins and ... of adjusting the force on the pins. ... or decreased by adjusting the pin carriers ...
Medicine Products: